Oriza Holdings
Northern Light leads Series B for China's TenNor Therapeutics
Northern Light Venture Capital (NLVC) has led a $25 million Series B funding round for TenNor Therapeutics, a Chinese drug developer specializing in infectious diseases.
PE-backed Linglong Tyre raises $388m in Shanghai IPO
Shandong Linglong Tyre, a leading Chinese tire manufacturer backed by Legend Capital and Hony Capital, has raised RMB2.6 billion ($388 million) in a Shanghai IPO.
WuXi, Boyu, Oriza commit $150m to China's CStone
WuXi Healthcare Ventures, Oriza Seed Venture Capital, and Boyu Capital have committed $150 million in Series A funding to Chinese bio-pharmaceutical developer CStone Pharmaceuticals.
PE-backed SF Express targets $6.6b Shenzhen reverse merger
China’s largest express delivery services provider SF Express, which is backed by several PE investors, is looking to list in Shenzhen through a reverse merger that values the business at RMB43.3 billion ($6.6 billion).
Renminbi fund-of-funds: Commercial remit
Renminbi-denominated fund-of-funds have found a new lease of life in China as new private sector entrants and reformed state-backed incumbents look to tap a growing domestic LP base